Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis

Area of Science:

• Immunology
• Regenerative Medicine
• Adipose Tissue Biology

Background:

• Adipose tissue's stromal vascular fraction (SVF) contains mesenchymal stem cells (MSC), regulatory T cells, and anti-inflammatory M2 macrophages.
• Autologous adipose tissue implantation is widely used in cosmetic surgery, and adipose-derived MSCs are under investigation.
• Preclinical studies in animals and limited human use for fistulas suggest SVF's anti-inflammatory and regenerative potential.

Purpose of the Study:

• To explore the rationale for using autologous SVF for systemic immune modulation in inflammatory diseases.
• To report initial clinical experiences with autologous SVF treatment in three multiple sclerosis patients.

Main Methods:

• Utilized autologous stromal vascular fraction (SVF) derived from adipose tissue.
• Administered SVF for potential systemic immune modulation in patients with multiple sclerosis.

Main Results:

• Initial experiences with three patients treated with autologous SVF for multiple sclerosis are described.
• The study highlights the potential of SVF for systemic immune modulation, though further controlled trials are needed.

Conclusions:

• Autologous SVF holds potential for treating inflammatory conditions, including multiple sclerosis, through immune modulation.
• Further controlled clinical trials are warranted to validate the efficacy and safety of SVF for systemic immune modulation in various inflammatory diseases.